baber/WOPTO huggingface dataset:
Patent AT-E54839-T1 (AT)
Inventor: PIETSCH GUENTHER
IPC: B01J13/06
Filed: 1988-02-17
Granted: 1990-08-15
Abstract: 1. Process for microencapsulating hydrophobic oils with colour reactants of colour reaction systems dissolved therein, a cationized melamine/formaldehyde precondensate being precipitated in ultra-fine suspension from its acid aqueous solution, accompanied by vigorous stirring and by modifying the solubility conditions, said suspension is mixed under vigorous stirring with a hydrophobic oil containing the colour reactants in dissolved form, the oil-in-water dispersion obtained is acid-adjusted and an aqueous solution of a water-soluble, non-ionic melamine/formaldehyde precondensate is added, accompanied by stirring, for forming the microcapsule envelope, characterized in that, for stabilizing the oil-in-water dispersion, the pH-value of the acid aqueous solution of a cationized melamine/formaldehyde precondensate which, in the weak acid, neutral and alkaline aqueous use range is present in insoluble cationizable form, is raised in the absence of water-soluble organic polymers by the addition of Bronsted bases and accompanied by vigorous stirring to such an extent that the cationizable melamine/formaldehyde precondensate is precipitated in ultra-fine suspension as a result of the modified solubility conditions.
Patent AT-E66650-T1 (AT)
Inventor: RAGUENEAU JEAN-PIERRE
IPC: B61F5/14
Filed: 1988-01-15
Granted: 1991-09-15
Abstract: The invention relates to a railway vehicle comprising two sets of two axles which are steerable relative to the body. The load of the body is applied in the vertical plane of each axle at two points adjacent to the wheels. The load of the body is applied through slide friction blocks. The invention concerns in particular railway vehicles wherein each axle is radially guided.
Patent AT-E92359-T1 (AT)
Inventor: CANTONI ANGELO
IPC: B01D35/14
Filed: 1988-04-11
Granted: 1993-08-15
Abstract: The filter according to the invention comprises an outer casing (1) which is provided with an end cover (5) having means (4) for connection to the engine lubrication circuit, and which houses a first filter pack or element (2) positioned to be traversed by the engine lubricating oil, there being provided a pressure relief valve (6) which prevents the oil passing through the first filter pack or element (2) in the case of excessive pressure drop, the pressure relief valve (6) cooperating with a piston element (13) associated with an electrically conducting spring (11) to establish electrical connection between a point of contact (12) and a part of the filter casing (1), a second filter pack or element (3) being positioned to filter part of the oil which the pressure relief valve (6) allows to pass in the case of high pressure drop in the oil flow through the first filter pack or element (2).
Patent AT-E73829-T1 (AT)
Inventor: DOMB ABRAHAM J
IPC: C08F8/20
Filed: 1988-02-25
Granted: 1992-04-15
Abstract: Hydroxamic acid polymers which are comprised of hydroxamic groups and carboxylic acid groups wherein the carboxylic acid groups constitute less than about 3% of the functional groups.The polymers hereof are also especially useful in biomedical applications because, for example, the low concentration of carboxylic acid groups decreases the incidence of bioincompatibility. Additionally, the polymers exhibit anticoagulant activity, urease inhibition activity, metal chelating activity and ion exchange activity.
Patent AT-E137119-T1 (AT)
Inventor: WALDMANN THOMAS A
IPC: A61K45/06
Filed: 1988-08-11
Granted: 1996-05-15
Abstract: The present invention relates to a method for treating malignancy and autoimmune disorders and for preventing allograft rejection. Conjugated or unconjugated monoclonal anti-Tac antibodies are employed to treat the above conditions. Clinical therapies have been designed to treat immune diseases and lymphomas in patients using conjugated anti-Tac antibodies.
Patent AT-E85346-T1 (AT)
Inventor: FORSSMANN WOLF-GEORG
IPC: G01N33/50
Filed: 1988-11-04
Granted: 1993-02-15
Abstract: Derivatives of precursor peptide of the cardiodilatine/atrial natriuretic factor (CDD-ANF) or fragments thereof which contain the amino acid sequence of alpha-hANaP. The derivatives are compounds having the formula (I). Also described is a process for qualitative and quantitative determination of peptides which contain the alpha-hANaP sequence and the use of the compounds of formula (I) as drugs.
Patent AT-E83881-T1 (AT)
Inventor: KOLLMEIER MANFRED DIPL-ING FH
IPC: H04L7/02
Filed: 1989-04-21
Granted: 1993-01-15
Abstract: A clock with the correct frequency and phase for a data signal is to be generated in a fully integrated arrangement. An auxiliary clock generator (2) generates a sequence of auxiliary clocks (HT1 - HT4). The frequency of these clocks is the same or differs slightly in a positive or negative direction, corresponding to the bit rate of the data signal (Da, Db). Moreover, their phase angles are identical to one another. A phase detector (7) compares the data signal with the auxiliary clocks (HT1 - HT4) and a control logic (8) selects one of these as a clock (T) via a changeover switch (9). An auxiliary clock (HT1 - HT4) is selected to which synchronous and spike-free changeover can be made. This method is suitable for clock recovery in digital signal multiplexing units on the F1an and F2an interface. <IMAGE>
Patent AT-E92323-T1 (AT)
Inventor: OGLETREE MARTIN L
IPC: A61P9/12
Filed: 1989-04-10
Granted: 1993-08-15
Abstract: A method is provided for preventing, reducing or reversing adverse reactions, such as pulmonary hypertension produced when protamine interacts with heparin, by administering a thromboxane A2 receptor antagonist.
Patent AT-E82117-T1 (AT)
Inventor: BIRTWISLE DAVID HOWARD
IPC: A61K8/00
Filed: 1989-11-30
Granted: 1992-11-15
Abstract: A composition suitable for topical application to the skin or hair, comprises:   a. a short chain dialkyl or dialkenyl phosphate salt having the structure (1): <CHEM>   and b. a monoalkyl or monoalkyl phosphate salt (or mixtures thereof), having the structure (2): <CHEM> where R<0><1> and R<0><2> are each chosen from branched or unbranched alkyl or alkenyl groups having an average of from 7 to 9 carbon atoms; R<0><3> is chosen from branched or unbranched alkyl or alkenyl groups having an average of from 6 to 18 carbon atoms; X, Y and Z are each chosen from H, alkali metal, ammonium and substituted ammonium counterions; and  a, b and c are each chosen from 0, or a value of from 1 to 4,
Patent AT-E86989-T1 (AT)
Inventor: BRION JEAN DANIEL
IPC: A61K31/352
Filed: 1989-04-13
Granted: 1993-04-15
Abstract: Compounds of general formula (I):  <IMAGE>  in which: R1, R2, R3 and R4, which may be identical or different, denote a hydrogen atom, a halogen atom or a lower alkyl, lower alkenyl, lower alkyloxy or lower alkenyloxy group, optionally substituted with one or more halogen atoms, R5 denotes a carboxyl, (lower alkyloxy)carbonyl, (lower alkenyloxy)carbonyl or (lower alkynyloxy)-carbonyl, their isomers, stereoisomers and diastereoisomers, and also their addition salts with a pharmaceutically acceptable base. Medicinal products.
Patent AT-E153704-T1 (AT)
Inventor: STEINMAN LAWRENCE
IPC: G01N33/564
Filed: 1989-04-26
Granted: 1997-06-15
Abstract: Polymorphic regions of the variable region gene of T-cell receptors can be identified as being associated with particular autoimmune diseases. By detecting the presence of the particular sequence in the host genome, particularly rearranged, or the T-cell receptor expression product, the propensity for the autoimmune disease may be diagnosed. In addition, antibodies or peptides related to the specific sequence may be prepared for use in prophylaxis and therapy.
Patent AT-E83738-T1 (AT)
Inventor: BOULANGER ALAIN
IPC: B09B1/00
Filed: 1989-05-26
Granted: 1993-01-15
Abstract: At the end of their leaching, the rock salt cavities 4 contain a large quantity of brine 8 whose temperature is lower than that of the enclosing mass of earth 2. It is consequently not possible to seal them quickly because of the progressive expansion of the brine as it warms up. The process of the present invention makes it possible to shorten the period between the end of exploitation of the cavity and its abandonment from about thirty years to approximately two years. 
<??>It consists in injecting into the cavity 4 quantities of a mixture 12 which is denser than the brine 8 and capable of setting, while equivalent quantities of brine 8 are discharged at the surface to keep the cavity 4 open at the end of the complete filling of the cavity 4 with the mixture 12, while the creep of the rock salt 2 closes the shrinkage voids which have appeared during the setting of the mixture 12, and in then sealing the cavity 4. It is advantageous, for this purpose, to employ chiefly wastes to constitute the mixture 12. 
<IMAGE>
Patent AT-E147784-T1 (AT)
Inventor: JOHNSON ERIC A
IPC: C12N1/16
Filed: 1989-08-07
Granted: 1997-02-15
Abstract: An economical process for the in vitro production of carotenoids, particularly the pigment astaxanthin, and particularly a process for enhancing astaxanthin content of cultures of microorganisms of genus Phaffia, the process comprising culturing a microorganism of genus Phaffia in a nutrient medium containing an antibiotic, cytochrome B inhibitor, or a terpenoid synthetic pathway inhibitor, or subjecting said microorganism to growth in the presence of a metabolic pathway inhibitor, particularly a main respiratory pathway inhibitor, in the presence of an influence which triggers a secondary respiratory pathway.
Patent AT-E99310-T1 (AT)
Inventor: HUEBSCH WALTER DR
IPC: A61P9/10
Filed: 1990-03-24
Granted: 1994-01-15
Abstract: The substituted 1,8-naphthyridines can be prepared by reduction of appropriate ketones, and, if appropriate, subsequent hydrolysis, cyclisation, hydrogenation and isomer separation. The substituted 1,8-naphthyridines can be used as active substances in medicaments.
Patent AT-E124630-T1 (AT)
Inventor: MASUDA ISAMU
IPC: A61N2/02
Filed: 1990-04-26
Granted: 1995-07-15
Abstract: The present invention relates to a magnetic field generating therapeutical apparatus which is applied for treatment of the stiffness, pain or the like of the patient's body part. Said apparatus is constructed by containing and arranging in a case a magnetic field generator composed of laminated iron core (20) and a coil bobbin (33). Said coil bobbin (33) is so made that a spool (31) is wound with a coil (33) around its peripheral surface and one of the collars (31D, 31U) provided at both ends of the spool is formed coinciding in equal thickness with the height of the protuberance (24a, 24b) of the laminated iron core (20) which is for concentrating the magnetic fluxes, the collar being positioned correspondingly to the position of the protuberance. For this reason no empty space will take place inside the coil, assuring to restrict the energy at the Portion to minimum, keeping off the danger of causing a burn to the patient's body. Furthermore, in the present invention the case is formed with some far-infrared radioactive substance blended or coated for exciting far-infrared rays. This will promote radiation of far-infrared rays to warm the patient's body from within, giving the efficient warming effect. <IMAGE>
Patent AT-E84483-T1 (AT)
Inventor: BERGER JOERG DR
IPC: B65B3/00
Filed: 1990-05-10
Granted: 1993-01-15
Abstract: The invention relates to a filling valve on a filling and closing machine with a filling container 1 for free-flowing products, in particular foodstuffs with lumpy ingredients. In order to prevent subsequent dripping or the formation of threads during the portioned drawing off of the free-flowing products, the filling valve has, in a mouthpiece, an axially movable valve slide 9 which, in the closed portion, can be set in vibration in the axial direction. The stroke of the vibration is dimensioned in such a manner that the closing function of the valve tappet 9 is maintained.
Patent AT-E99055-T1 (AT)
Inventor: GRZESNY ROLF DIPL-ING
IPC: G01N33/18
Filed: 1990-05-16
Granted: 1994-01-15
Abstract: The invention relates to an apparatus for determining the biochemical oxygen demand and the toxicity, particularly of waste water, having a reaction container 1 comprising a reaction space 11 for receiving a liquid sample, an electrolyser 2 having electrodes 14, 19, an absorber 6 which can be placed in the reaction container and a control and measured value processing device which can be connected to the electrolyser 2. In order, in particular, to improve such an apparatus in such a way that it is even possible to measure heavily polluted waste water as a routine operation in a constructionally simple manner and with reduced space requirements, the reaction container 1 and the electrolyser 2 form a separable unit. In addition, the electrolyser 2 has a riser tube which opens into the reaction space 1.1 of the reaction container 1. The electrolyser 2 has chambers which are connected in terms of flow and which each have an electrode 14 or 17. The free chamber gas spaces 2.3, 9.1 can be separated from one another by an electrolysis liquid. The electrolyser 2 can be inserted in the reaction container 1 and has a vessel section 2.1 which forms one of the chambers and to which the riser tube 9 which opens into the free reaction space forming the other reaction chamber is connected.
Patent AT-E128332-T1 (AT)
Inventor: SU PETER
IPC: A45B19/10
Filed: 1990-07-11
Granted: 1995-10-15
Abstract: A triple-folding umbrella skeleton includes a plurality sets of frame arranged around the middle tube (7) and pivotably mounted on the notch (71) and runner (72) respectively. Each frame set includes a first rib (1) a second rib (2), a third rib (3) a stretcher (4) and a first link (5). One end of the first rib (1) is pivotably mounted on the runner (72). The two ends of the second rib (2) is pivotably mounted to the other end of the first rib (1) and one end of the third rib (3) respectively. One end of the stretcher (4) is pivotably mounted on the notch (71), and the other end of the stretcher (4) is pivotably mounted to the first rib (1). The first link (5) is generally parallel to the first rib (1), and its two ends is pivotably mounted to a first entension portion (20) of the second rib and the stretcher (4) respectivley. The first line (5), the stretcher (4), the first rib (1) and the first extension portion (20) cooperate to form a quadric link structure. The triple-folding umbrella skeleton is characterized in that each frame set further includes a connecting spring (9) and a second link (8) generally parallel to the second rib (2). One end of the second link (3) is pivotably mounted to a second extension portion (30) of the third rib, and the other end of the second link is connected to the first rib (1) via the connecting spring (9). Whereby, each frame set can be expanded to a largest extent to obtain a largest canopy shielding area, and only a smaller force is needed to open the triple-folding umbrella skeleton, due to the retractability of the connecting spring. <IMAGE>
Patent AT-E143660-T1 (AT)
Inventor: YOSHINO SUMIO
IPC: C07D239/60
Filed: 1990-07-24
Granted: 1996-10-15
Abstract: A process for producing a 4,6-bis(difluoromethoxy)-2-alkylthiopyrimidine, which comprises reacting a 2-alkylthiobarbituric acid and monochlorodifluoromethane in the presence of a base in an inert solvent, wherein, for a first reaction, after charging a part of the base, the rest of the base and the monochlorodifluoromethane are simultaneously introduced to obtain a mixture of a 4-difluoromethoxy-6-hydroxy-2-alkylthiopyrimidine and a 4,6-bis(difluoromethoxy)-2-alkylthiopyrimidine, and then, for a second reaction, to this mixture, the base and the monochlorodifluoromethane are again simultaneously introduced, or the base is charged first and then the monochlorodifluoromethane is introduced.
Patent AT-E108057-T1 (AT)
Inventor: VAN ENGELAND WIL
IPC: A47B17/02
Filed: 1990-01-18
Granted: 1994-07-15
Abstract: The invention relates to a height-adjustable table comprising at least two legs of adjustable length, each comprising: two leg portions telescopically slidable relative to one another and fixable in a chosen position, the lower of which may optionally support via a foot on the ground and the upper of which is coupled to a table top with coupling means, and drive means for sliding the leg portions relative to one another and coupling means for joint sliding of the leg portions of all legs such that these always have the same length, which drive means comprise:  an operating mechanism such as a hand-operable crank or motor, and a screw spindle and nut co-acting therewith, of which the one is connected fixedly to the one portion of a leg and the other is connected rotatably and axially locked to the other portion of this leg and which can be set into rotation by the operating mechanism. In order to enable a very reliable height adjustment acting with little friction using very simple mechanical means, the embodiment is recommended which is characterized by a right angle transmission gear added to each leg and forming part of the drive means.
Patent AT-E90120-T1 (AT)
Inventor: UPHUES GUENTER
IPC: D06M13/02
Filed: 1990-01-15
Granted: 1993-06-15
Abstract: PCT No. PCT/EP90/00075 Sec. 371 Date Jul. 23, 1991 Sec. 102(e) Date Jul. 23, 1991 PCT Filed Jan. 15, 1990 PCT Pub. No. WO90/08217 PCT Pub. Date Jul. 26, 1990.Textile treatment preparations based on the condensates of aliphatic monocarboxylic acids or amide-forming derivatives thereof with optionally hydroxyl-substituted polyamines and an addition of dispersion accelerators from the group of certain monosaccharides and hydrogenation products thereof, polyols and natural and synthetic hydrophilic polymers show particularly good dispersibility, even in cold water, if the amino groups unreacted during the condensation reaction are only partly neutralized with low molecular weight, optionally hydroxyl-substituted mono- or polycarboxylic acids.
Patent AT-E90000-T1 (AT)
Inventor: THEEUWES FELIX
IPC: A61M5/14
Filed: 1990-02-14
Granted: 1993-06-15
Abstract: PCT No. PCT/US90/00880 Sec. 371 Date Aug. 12, 1991 Sec. 102(e) Date Aug. 12, 1991 PCT Filed Feb. 14, 1990 PCT Pub. No. WO90/09201 PCT Pub. Date Aug. 23, 1990.An agent formulator (30, 60) for an intravenous administration set (14) is provided. The intravenous administration set (14) includes a container (12) of an IV fluid (13), a drip chamber (22), an agent formulator (30, 60) and an adapter-needle assembly (28). The agent formulator (30, 60) has a fluid inlet (23) and a fluid outlet (25) for maintaining a flow of IV fluid (13 ) therethrough. A portion (36) of the formulator wall (32) is comprised of a window material which allows the agent to diffuse therethrough but which prevents convective loss of the IV fluid (13). A flow distributor (38, 68) is provided within the chamber for distributing the flow of IV fluid (13) along the interior surface of the window (36). A transdermal-type drug delivery device (40) is adhered to the exterior surface of the window (36). Drug is delivered by the delivery device (40) through the window (36) and into the flowing IV fluid (13). The device (40) delivers drug into the IV fluid (13) at a rate that is independent of the flow rate of IV fluid (13) through the formulator (30, 60). The rate of drug delivery from the device (40) into the IV fluid (13) is controlled by either the window (36) itself or by a membrance layer (46) in the drug delivery device (40). A plurality of drug delivery devices (40) may be adhered to the window (36) to deliver a plurality of drugs or to deliver a single drug at a higher dosage rate. A similar window (11) may be placed in a IV bag to deliver a drug into the IV fluid therein.
Patent AT-E125449-T1 (AT)
Inventor: FREDERICKSEN TOMMY L
IPC: A01K67/00
Filed: 1990-05-22
Granted: 1995-08-15
Abstract: METHOD OF TREATING ANIMALS A method of causing an animal to gain weight by administering that animal a T-cell growth factor comprising Interleukin-2 (IL-2) in an amount effective to cause that animal to increase in weight is disclosed. A method of treating birds by administering birds in ovo avian IL-2 is also disclosed. The method is preferably carried out on chickens with 30K chicken IL-2 on about the eighteenth day of incubation. The method may be employed to increase the weight of treated birds after hatch. A vaccine may optionally be administered concurrently with the avian IL 2.
Patent AT-E148366-T1 (AT)
Inventor: ROSENBLATT AARON A
IPC: B01D53/00
Filed: 1990-09-17
Granted: 1997-02-15
Abstract: A method and apparatus for the generation, use, and disposal of chlorine dioxide is disclosed. A solid sodium chlorite composition having impurities, at least one of which is sodium hydroxide, is contacted with an agent to consume essentially all of the sodium hydroxide. Chlorine dioxide gas is then generated by contacting the resultant composition with chlorine in a humidified inert carrier gas. The resultant chlorine dioxide gas mixture may then be treated to remove chlorine gas present therein by contacting the same with soda-lime in particulate form. After using the chlorine dioxide gas mixture in the desired manner, chlorine dioxide present in the spent effluent gas may be substantially removed via the introduction of the effluent gas into an aqueous solution of sodium thiosulfate having a sufficient amount of an inorganic base to maintain the alkalinity of the solution during consumption of thiosulfate by chlorine dioxide.
Patent AT-E144331-T1 (AT)
Inventor: ZERTANI RUDOLF DR DIPL-CHEMIKE
IPC: G03F7/20
Filed: 1991-03-27
Granted: 1996-11-15
Abstract: A posttreatment apparatus 1 for printing plates 30 which have been exposed to an image comprises an exposure station 2 and a hot station 3 which are situated one behind the other in the direction of conveyance of the printing plates along a conveyance track 12 through the posttreatment apparatus 1. The exposure station 2 contains a controllable radiation source 8 for exposing the entire surface of the printing plates. The housing of the exposure station 2 has an exposure opening 13 at the bottom which is covered by a filter disc 9. The housing of the hot station 3 is thermally insulated on three sides and open at the bottom in the direction of a reflector table 7 across which the printing plates are passed.
Patent AT-E127016-T1 (AT)
Inventor: HORSTMANN MICHAEL DR
IPC: A61J3/00
Filed: 1991-06-04
Granted: 1995-09-15
Abstract: An administration form which in the form of a sheet makes possible single dosage of pharmaceuticals, confectionery, other foodstuffs, cosmetics and the like for oral use or intake is characterised in that it contains a mixture of 20 to 60% by weight of at least one film former, 2 to 40% by weight of at least one gel former, 0.1 to 35% by weight of at least one active substance and up to 40% by weight of at least one inert filler on a carrier, or consists of a mixture of the said composition without carrier. Manufacture involves preparation of an intimate mixture of these components, optionally adding up to 30% by weight of a polar solvent, and processing to a homogeneous mixture which can be spread or extruded.